Total Payments
$234,728
2024 Payments
$89,930
Companies
51
Transactions
1,500
Medicare Patients
4,736
Medicare Billing
$472,022
Payment Breakdown by Category
Other$140,435 (59.8%)
Food & Beverage$32,349 (13.8%)
Consulting$27,801 (11.8%)
Research$21,769 (9.3%)
Travel$12,050 (5.1%)
Education$324.72 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $140,260 | 33 | 59.8% |
| Food and Beverage | $32,349 | 1,355 | 13.8% |
| Consulting Fee | $27,801 | 17 | 11.8% |
| Unspecified | $21,769 | 19 | 9.3% |
| Travel and Lodging | $12,050 | 67 | 5.1% |
| Education | $324.72 | 8 | 0.1% |
| Honoraria | $175.00 | 1 | 0.1% |
Payments by Type
General
$212,959
1,481 transactions
Research
$21,769
19 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CIPLA USA INC. | $77,460 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $32,092 | 92 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $27,642 | 81 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $21,656 | 111 | $0 (2024) |
| Glenmark Pharmaceuticals Inc. | $16,871 | 3 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $15,304 | 215 | $0 (2024) |
| GENZYME CORPORATION | $11,806 | 103 | $0 (2024) |
| Genentech USA, Inc. | $6,611 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $6,455 | 244 | $0 (2024) |
| PFIZER INC. | $3,808 | 83 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $89,930 | 236 | CIPLA USA INC. ($77,395) |
| 2023 | $8,406 | 256 | AstraZeneca Pharmaceuticals LP ($3,976) |
| 2022 | $4,894 | 229 | AstraZeneca Pharmaceuticals LP ($689.26) |
| 2021 | $2,727 | 148 | GlaxoSmithKline, LLC. ($499.89) |
| 2020 | $5,751 | 116 | Genentech USA, Inc. ($1,748) |
| 2019 | $27,226 | 159 | Regeneron Healthcare Solutions, Inc. ($7,913) |
| 2018 | $52,156 | 181 | Glenmark Pharmaceuticals Inc. ($16,871) |
| 2017 | $43,639 | 175 | Teva Pharmaceuticals USA, Inc. ($23,824) |
All Payment Transactions
1,500 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Immunology and Neurology | ||||||
| 12/17/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $34.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $25.82 | General |
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Respiratory | ||||||
| 12/11/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Pulmonology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Immunology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Immunology | ||||||
| 11/20/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Immunology and Neurology | ||||||
| 11/14/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $39.52 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/13/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER CLINICAL STUDY TO ASSESS THE EFFICACY AND SAFETY OF TWICE DAILY ADMINISTRATION OF FLUTICASONE PROPIONATE 100 MCG AND SALMETEROL XINAFOATE 50 MCG DRY POWDER INHALER COMPARED TO ADMINISTRATION WITH ADVAIR DISKUS 10050 MCG TWICE DAILY AND PLACEBO IN PATIENTS 12 YEARS OF AGE AND OLDER WITH REVERSIBLE PERSISTENT ASTHMA INCLUDING A 3-WEEK OPEN-LABEL EXTENSION TO ASSESS INHALER ROBUSTNESS | Lupin Inc. | $2,500 | 1 |
| A Randomised PhIII study to assess the effect of 100 mg SC Mepolizumab in the nasal polyp score and symptoms in subjects with bilateral Nasal polyps NP and in current need of NP surgery | GlaxoSmithKline, LLC. | $1,027 | 6 |
| A RANDOMISED PHIII STUDY TO ASSESS THE EFFECT OF 100 MG SC MEPOLIZUMAB | GlaxoSmithKline, LLC. | $793.39 | 6 |
| A Randomized, Blinded, Parallel Group, Placebo-Controlled, Multiple Dose, Multicenter Study to Compare the Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent HFA 110 mcg, in Adult Subjects With Asthma | Teva Pharmaceuticals USA, Inc. | $137.47 | 1 |
| A MULTICENTER, RANDOMIZED, PARALLEL-GROUP, PLACEBO-CONTROLLED, 4-WEEK CLINICAL ENDPOINT BIOEQUIVALENCE STUDY COMPARING FLUTICASONE PROPIONATE/SALMETEROL 100/50 MCG INHALATION POWDER (CIPLA LTD., INDIA) WITH ADVAIR DISKUS 100/50 MCG (GLAXOSMITHKLINE, USA) IN ASTHMA PATIENTS. | CIPLA USA INC. | $65.69 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,383 | 10,049 | $225,166 | $130,692 |
| 2022 | 12 | 1,174 | 7,519 | $196,843 | $121,951 |
| 2021 | 13 | 1,054 | 7,711 | $174,671 | $110,820 |
| 2020 | 18 | 1,125 | 9,296 | $189,024 | $108,560 |
Total Patients
4,736
Total Services
34,575
Medicare Billing
$472,022
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 406 | $56,840 | $39,689 | 69.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 101 | 6,167 | $49,396 | $21,191 | 42.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 103 | 1,673 | $29,278 | $20,243 | 69.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 151 | $15,100 | $10,953 | 72.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $17,375 | $10,567 | 60.8% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 228 | 300 | $19,500 | $9,144 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 25 | $4,875 | $3,746 | 76.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 174 | 230 | $6,440 | $3,507 | 54.5% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 14 | 173 | $5,190 | $2,968 | 57.2% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 77 | 341 | $6,820 | $2,571 | 37.7% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 56 | 213 | $6,390 | $2,014 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $2,470 | $1,661 | 67.2% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 41 | 185 | $1,758 | $1,291 | 73.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 61 | $2,135 | $620.09 | 29.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 16 | 16 | $1,600 | $527.36 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 278 | 378 | $52,920 | $37,822 | 71.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 112 | 1,983 | $34,703 | $26,090 | 75.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 179 | $17,900 | $12,778 | 71.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 64 | 3,402 | $27,216 | $12,245 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $15,795 | $10,727 | 67.9% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 171 | 201 | $13,065 | $6,563 | 50.2% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 79 | 552 | $11,040 | $4,222 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 27 | $5,265 | $3,917 | 74.4% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 53 | 312 | $9,360 | $2,851 | 30.5% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 117 | 138 | $3,864 | $2,253 | 58.3% |
About Dr. Jonathan Matz, M.D
Dr. Jonathan Matz, M.D is a Allergy healthcare provider based in White Marsh, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013966100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Matz, M.D has received a total of $234,728 in payments from pharmaceutical and medical device companies, with $89,930 received in 2024. These payments were reported across 1,500 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($140,260).
As a Medicare-enrolled provider, Matz has provided services to 4,736 Medicare beneficiaries, totaling 34,575 services with total Medicare billing of $472,022. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location White Marsh, MD
- Active Since 05/08/2006
- Last Updated 01/21/2021
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1013966100
Products in Payments
- CINQAIR (Drug) $25,640
- XOLAIR (Biological) $22,257
- DUPIXENT DUPILUMAB INJECTION (Biological) $12,792
- DUPIXENT (Biological) $10,885
- DUPIXENT (Drug) $9,893
- AIRSUPRA (Drug) $7,341
- Xolair (Biological) $6,884
- NUCALA (Biological) $4,143
- EUCRISA (Drug) $3,537
- BREZTRI (Drug) $2,895
- ADVAIR (Drug) $2,500
- FASENRA (Drug) $2,003
- TEZSPIRE (Biological) $1,355
- RESLIZUMAB (Drug) $1,216
- CUVITRU (Biological) $1,176
- TRELEGY ELLIPTA (Drug) $1,128
- Hizentra (Biological) $1,123
- Xhance (Drug) $1,116
- Xembify (Biological) $1,088
- FASENRA (Biological) $985.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.